ArticleCureus2025
Pituitary Apoplexy: A Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case report of two growth hormone-secreting invasive pituitary adenomas and literature review.Archives of medical science : AMS · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pituitary apoplexy (PA) is a rare but potentially life-threatening endocrine emergency, typically resulting from sudden-onset haemorrhage within the pituitary gland. If not promptly diagnosed and managed, it can lead to severe hormonal disturbances and neuro-ophthalmic complications with fatal consequences. Early recognition is crucial for improving patient outcomes. Certain conditions increase susceptibility to PA, including pre-existing pituitary adenomas (most commonly non-functioning), the postpartum period, diabetes mellitus, hypertension, sickle cell anaemia, and acute shock. Here, we describe five cases of PA, each with varied signs and symptoms, which underscores the clinical heterogeneity with which pituitary apoplexies can present. The first and second patients exhibited significant pituitary dysfunction and hyponatremia, necessitating steroid replacement and supportive care, leading to gradual recovery. The third patient presented with an incidental MRI finding of pituitary haemorrhage and remained hemodynamically stable without any evidence of hypopituitarism. The fourth case presented with cranial nerve palsies, while the fifth case, which presented as a prolactinoma, had apoplexy after starting cabergoline therapy. A high index of suspicion is essential for timely diagnosis. Emergency magnetic resonance imaging (MRI) of the sellar region is the gold standard for confirming the diagnosis. Rapid intervention, including appropriate hormonal replacement and neurosurgical evaluation, can be life-saving. This case series highlights the diverse clinical presentations of PA and outlines a structured approach to its management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.